BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Kidney
,
Personalized medicine
,
Fenofibrate
,
rs2230926
,
SNCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mir‑ 205 human
Summary
General Info
Curated Studies
Most Correlated Studies
Ovarian HEY cells overexpressing miR-141, miR-200b or miR-205 or with ZEB1 and WNT5A siRNA knockdown
AGO2-associated transcripts in prostate cancer cells overexpressing miR-130a, miR-203, or miR-205
Study of the role of miR-205 in prostate epithelial cells
Prostate cancer PC-3 cells overexpressing miR-205, AGO2 bound RNAs
Prostate cancer LNCaP cells overexpressing miR-130a, miR-203, and miR-205 microRNAs
Explore Curated Studies Results
Literature
Most Relevant Literature
MiR-205-3p protects human corneal epithelial cells from ultraviolet damage by inhibiting autophagy v…
Long non-coding RNA CACNA1G-AS1 promotes proliferation and invasion and inhibits apoptosis by regula…
MicroRNA-205-5p: A Potential Therapeutic Target for Combating Unstable Atherogenesis?
miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cells…
MicroRNA-205 targets HER3 and suppresses the growth, chemosensitivity and metastasis of human nasoph…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMIC…
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2…
Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Al…
Changes of Exosomes and Biomarkers in Plasma and Alveolar Lavage Fluid of Patients With Sepsis Compl…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ